Google Glass gets backing from venture capital firms. A number of venture capital firms have teamed up to provide funding for companies working on Google Glass.
North America
Serent Capital to Invest with Optimal Blue
Serent Capital agrees to invest in Optimal Blue. Serent Capital has invested in leading mortgage technology provider, Optimal Blue. Serent Capital is a leading San Francisco-based private equity firm that focuses on investing with high growth and profitable companies.
Rio Tinto's Turquoise Hill Selling off its Ivanhoe Shareholdings
In a bid to divest assets to raise funds, Rio Tinto's Turquoise Hill is selling off its Ivanhoe shareholdings.
UPDATE - Deutsche Telekom Cuts Debt Load
New terms have been added to sweeten the MetroPCS-T Mobile deal. In a bid to woo investors to vote for the merger, Deutsche Telekom had reduced the level of the merged company's debt for the proposed T-Mobile USA and MetroPCS merger.
AXA SA Sells Off Policies from US Unit to Protective Life
In a deal worth US$1 billion, AXA SA would transfer assets from its US unit to Protective Life. A deal was recently announced where Protective Life Corp.
Latest News
Before the MetroPCS shareholder meeting, the shareholders that had filed suit are now wondering the next move the merging firms.
KGHM, with a goal towards being the top copper producer, is ramping up its acquisitions every two or three years.
First Manhattan Company, Vivus top shareholder, is calling out the risk management strategy as insufficient to ensure the drug Qsymia's success.
Australian surfwear firm Billabong announced that it has entered into a 10-day exclusive takeover talks with its former head Paul Naude and private equity firm Sycamore Partners.
Carlyle Group purchases Central Plaza for US$267 million from Forterra Trust. Private equity giant the Carlyle Group has announced the acquisition of the Central Plaza for US$267 million.
Options City receives financing from Edison Ventures. Edison Ventures announced its capital investment in OptionsCity Software, a provider of electronic trading platforms.
The recent decline of an offer and its sudden stop in its search for a partner has put Gleacher in deeper issues moving forward.
InnoBio joins experts for drug research InnoBio, a biotech fund managed by CDC Enterprises, had announced its joint venture with Sofinnova Partners in MedDay for the cost of EUR 8 Million or $10.
WellTok Completes new series B round funding. The developer of CafeWell, the top Social Health Management Platform has announced the completion of its Series B funding activities.
